Combining antiviral therapy with cancer treatment in HBV-associated HCC: A translational approach
Md Abul Hashem, Mohammad Enamul Hoque Kayesh, Michinori Kohara, Kyoko Tsukiyama-Kohara · 2026
Read Combining antiviral therapy with cancer treatment in HBV-associated HCC: A translational approach by Md Abul Hashem, Mohammad Enamul Hoque Kayesh, Michinori Kohara, Kyoko Tsukiyama-Kohara (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13671042.txt.
Description
Hashem, Kayesh, Kohara, and Tsukiyama-Kohara review the case for treating liver cancer and its root virus at the same time. Hepatitis B drives much liver cancer worldwide. Their 2026 review notes a split problem. Antiviral drugs cut viral load and liver inflammation, but they cannot clear viral DNA woven into liver cells. Cancer treatments alone fare poorly when the virus stays active.
Combining both attacks looks more promising, the authors argue. They cover how the virus sparks cancer, and how antivirals cut recurrence after cancer treatment. They also weigh the risk that cancer therapy wakes the virus again. New markers, gene editing aimed at viral stores, and gut microbe links all get attention. The review backs a dual plan aimed at long remission.
Catalog record
| CREATOR | Md Abul Hashem, Mohammad Enamul Hoque Kayesh, Michinori Kohara, Kyoko Tsukiyama-Kohara |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 66 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |